Abstract
Noninvasive prenatal genetic tests analyzing the cell-free fetal DNA in the circulation of expectant mothers are now performed routinely in clinical diagnostic laboratories. Leveraging the power of next generation sequencing (NGS), these tests can detect variation in chromosomal copy number or microdeletions early in gestation. All methods begin with blood collection followed by transport to the diagnostic lab, plasma separation, and purification of ccfDNA from the plasma to prepare it for molecular analysis. Preservation of ccfDNA in blood samples and highly efficient purification from plasma are paramount since the quality and quantity of target nucleic acids determine the sensitivity and therefore success of these assays. Maximizing quality and quantity and minimizing variation in extraction yield pose significant challenges for diagnostic labs, many of which use manual isolation methods for plasma volumes greater than 5 mL. One way to reduce variability is to automate the extraction processes and, to the extent possible, minimize hand-on operations. This chapter details two procedures for isolating ccfDNA from 10 mL plasma by manual and automated means using the QIAamp Circulating Nucleic Acid Kit and the QIAsymphony Circulating DNA Kit. The ccfDNA recovered is suitable for downstream processing in noninvasive prenatal tests for aneuploidy detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Houk BE, Hochhaus G, Hughes JA (1999) Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS PharmSci 1(3):E9
Tamkovich SN, Cherepanova AV, Kolesnikova EV, Rykova EY, Pyshnyi DV, Vlassov VV, Laktionov PP (2006) Circulating DNA and DNase activity in human blood. Ann N Y Acad Sci 1075:191–196. https://doi.org/10.1196/annals.1368.026
Steinman CR (1975) Free DNA in serum and plasma from normal adults. J Clin Invest 56(2):512–515. https://doi.org/10.1172/JCI108118
Gormally E, Hainaut P, Caboux E, Airoldi L, Autrup H, Malaveille C, Dunning A, Garte S, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Boffetta P, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ, Quiros JR, Berglund G, Hallmans G, Day NE, Key TJ, Veglia F, Peluso M, Norat T, Saracci R, Kaaks R, Riboli E, Vineis P (2004) Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer 111(5):746–749. https://doi.org/10.1002/ijc.20327
Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37(3):646–650
Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4):1659–1665
Raptis L, Menard HA (1980) Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66(6):1391–1399. https://doi.org/10.1172/JCI109992
Zeerleder S (2006) The struggle to detect circulating DNA. Crit Care 10(3):142. https://doi.org/10.1186/cc4932
Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579. https://doi.org/10.1038/nri855
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076):485–487
Sekizawa A, Yokokawa K, Sugito Y, Iwasaki M, Yukimoto Y, Ichizuka K, Saito H, Okai T (2003) Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet 113(4):307–310. https://doi.org/10.1007/s00439-003-0987-4
Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62(4):768–775
Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50(1):88–92. https://doi.org/10.1373/clinchem.2003.024893
Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR (2010) Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem 56(8):1279–1286. https://doi.org/10.1373/clinchem.2010.144188
Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S (2004) Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 50(6):1002–1011. https://doi.org/10.1373/clinchem.2003.029835
Barrett AN, Zimmermann BG, Wang D, Holloway A, Chitty LS (2011) Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield. PLoS One 6(10):e25202. https://doi.org/10.1371/journal.pone.0025202
Hall MP, Hill M, Zimmermann B, Sigurjonsson S, Westemeyer M, Saucier J, Demko Z, Rabinowitz M (2014) Non-invasive prenatal detection of trisomy 13 using a single nucleotide polymorphism- and informatics-based approach. PLoS One 9(5):e96677. https://doi.org/10.1371/journal.pone.0096677
Samango-Sprouse C, Banjevic M, Ryan A, Sigurjonsson S, Zimmermann B, Hill M, Hall MP, Westemeyer M, Saucier J, Demko Z, Rabinowitz M (2013) SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 33(7):643–649. https://doi.org/10.1002/pd.4159
Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, Grankvist K, Huisman W, Kouri T, Palicka V, Plebani M, Puro V, Salvagno GL, Sandberg S, Sikaris K, Watson I, Stankovic AK, Simundic AM (2011) Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 49(7):1113–1126. https://doi.org/10.1515/CCLM.2011.600
Horlitz M, Hartinger T, Graf S, Lucas A, Nocon A, Sprenger-Haussels M (2011) Yields of viral and circulating cell-free nucleic acids using the QIAamp (R) circulating nucleic acid kit. Circulating Nucleic Acids in Plasma and Serum:259–268. https://doi.org/10.1007/978-90-481-9382-0_35
Disclaimer
The scalable ccfDNA isolation methods presented here are for performance evaluations only.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Stray, J., Zimmermann, B. (2019). Isolation of Cell-Free DNA from Maternal Plasma. In: Levy, B. (eds) Prenatal Diagnosis. Methods in Molecular Biology, vol 1885. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8889-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8889-1_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8887-7
Online ISBN: 978-1-4939-8889-1
eBook Packages: Springer Protocols